Injectable chemotherapy vs capecitabine: Preference in Brazilian patients

被引：0
|
作者：
Boscatti, F. H. G. [1 ]
机构：
[1] Prod Roche Quim & Farmaceut SA, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70257-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A78 / A79
页数：2
相关论文
共 50 条
  • [21] Training nurses to treat patients in the UK with oral chemotherapy: the capecitabine nurse toolkit
    Harrold, K.
    Craven, O.
    Bennett, K.
    Aston, V.
    Gent, P.
    MacLeod, A.
    Vidall, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 485 - 485
  • [22] METRONOMIC CAPECITABINE AS SALVAGE CHEMOTHERAPY IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL CANCER (AGIC)
    Barucca, V
    Romiti, A.
    Sarcina, I
    Di Rocco, R.
    Morelli, F.
    Durante, V
    Marchetti, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 112 - 112
  • [23] Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
    Ju Hyun Shim
    Joong-Won Park
    Byung Ho Nam
    Woo Jin Lee
    Chang-Min Kim
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 459 - 467
  • [24] Salvage Chemotherapy with Oxaliplatin and Capecitabine for Breast Cancer Patients Pretreated with Anthracyclines and Taxanes
    Polyzos, Aristides
    Gogas, Helen
    Markopoulos, Christos
    Tsavaris, Nikolas
    Papadopoulos, Othon
    Polyzos, Kostas
    Giannopoulos, Athanasios
    ANTICANCER RESEARCH, 2009, 29 (07) : 2851 - 2856
  • [25] Capecitabine: effective oral fluoropyrimidine chemotherapy
    McKendrick, J
    Coutsouvelis, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (07) : 1231 - 1239
  • [26] Impact of chemotherapy-induced peripheral neuropathy permanence on patients' preference to discontinue chemotherapy
    Jun, Yerial
    Tao, Xueting
    Chen, Ciao-Sin Chelsea
    Griggs, Jennifer J.
    Kidwell, Kelley M.
    Hertz, Daniel Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Significant predictors of preference for inhaled versus injectable insulin in patients with type 2 diabetes
    Hayes, R. P.
    Stump, T. E.
    Muchmore, D. B.
    Schmitkel, J.
    DIABETOLOGIA, 2007, 50 : S402 - S402
  • [28] EFFICACY AND PREFERENCE FOR DYMISTA VS PRIOR TREATMENTS IN RHINITIS PATIENTS
    Kaliner, M. A.
    White, M. V.
    Ward, C.
    Scarupa, M.
    Economides, A.
    Johnson, T.
    Wheling, C.
    Li, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A117 - A117
  • [29] Efficacy and safety of capecitabine as maintenance therapy after capecitabine-based combination chemotherapy for patients with advanced esophagogastric junction adenocarcinoma
    Lu, B.
    Bao, L. -B.
    Sun, Z.
    Hua, Z. -L.
    Wang, X.
    Qu, C. -P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (19) : 3605 - 3612
  • [30] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: disease free survival results at interim analysis
    Schmoll, H-J.
    Haustermans, K.
    Price, T.
    Nordlinger, B.
    Hofheinz, R. D.
    Daisne, J-F.
    Janssens, J.
    Brenner, B.
    Schmidt, P.
    Reinel, H.
    Hollerbach, S.
    Caca, K.
    Fauth, F.
    Hannig, C. V.
    Zalcberg, J.
    Tebbutt, N.
    Mauer, M. E.
    Messina, C.
    Lutz, M.
    Van Cutsem, E.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S6 - S6
12345